Abstract 3132: Immune regulatory gene expression and clinical outcome in the NeoALTTO trial
Sign Up to like & getrecommendations! Published in 2019 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs18-3132
Abstract: Background: The level of immune suppression in an individual breast cancer (BC) patient is relevant for having a major benefit from treatments that act via or are directed to the immune response, such as anti-HER2… read more here.
Keywords: expression; neoaltto trial; pcr; regulatory gene ... See more keywords